U.S., Oct. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07204678) titled 'PMCF Study of Precise Pro Rx for Carotid Artery Disease' on Sept. 24.
Brief Summary: The purpose of this study is to evaluate long-term clinical safety and performance of the PRECISE PRO RX Nitinol Stent System to treat stenotic lesions of the carotid arteries.
Study Start Date: Sept. 30
Study Type: OBSERVATIONAL
Condition:
Carotid Artery Stenosis
Intervention:
DEVICE: PRECISE PRO Rx Nitinol Stent System
The Cordis PRECISE PRO Rx Nitinol Stent System is a single-use device consisting of an endovascular stent and sheath delivery system, intended to deliver a self-expanding endovascular stent to the carotid artery(ies). The sten...